Is artificial intelligence overhyped? Not a chance, according to analysts at Truist Securities. They say AI will shake up the entire economy and are
Author: admin
Trump says his Greenland fixation is about national security. Europeans are skeptical.
Denmark’s prime minister urged the U.S. to increase its military presence in Greenland but the White House showed little interest in the offer.
From Greenland to Iran: Trump’s threats stretch far and wide since his Venezuela strike
Since the seizure of Venezuelan President Nicolás Maduro by US forces at the weekend, US President Donald Trump and members of his administration have
Trump’s Venezuela oil grab revives ‘petrodollar’ debate
There were likely many motives behind America’s capture and arrest of Venezuelan President Nicolas Maduro on Saturday, but one little-discussed factor could be the
ISRA: Israeli Stocks Remain Attractive At The Start Of 2026
The VanEck Israel ETF invests primarily in large-cap Israeli stocks with a market capitalization of over $5 billion. Click here to read an analysis
Can Pure-Play Quantum Stocks Really Make You $5 Million in 10 Years?
The smaller players in this developing technology have taken their shareholders on quite the roller-coaster ride.
Wall Street mixed in light trading before the opening bell while oil prices resume their climb
Trading on Wall Street was mixed in light trading early Tuesday while gains for oil prices moderated following the U.S. military operation in Venezuela
Trump’s Latest Move on Tariffs Makes These 2 Stocks a Buy for 2026
The president postponed an import tax hike that would have put pressure on companies like RH and Wayfair. Two stocks surged Monday in the
Bourbon’s trade war blues hit hard
The bourbon world is facing some tough times, and it’s not just a rough morning after a long night out. Kentucky’s famous whiskey makers
Helus Pharma Rings the Opening Bell
About This EventHelus Pharma (Nasdaq: HELP), a clinical-stage pharmaceutical company committed to helping minds heal through the development of novel serotonergic agonists (NSAs), visits